INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.02 Million | 822.19 Thousand | 4.16 Million | 1.03 Million | 1.48 Million | 494.37 Thousand |
| Cost of Revenue | 1.93 Million | 331.52 Thousand | 145.05 Thousand | 88.76 Thousand | 139.67 Thousand | 90.36 Thousand |
| Gross Profit | 1.08 Million | 490.67 Thousand | 4.01 Million | 948.52 Thousand | 1.34 Million | 404 Thousand |
| Operating Expenses | 7.85 Million | 11.11 Million | 9.23 Million | 6.46 Million | 3.12 Million | 3.03 Million |
| Selling, General and Administrative Expenses | 7.48 Million | 10.57 Million | 9.01 Million | 6.06 Million | 3.12 Million | 3.03 Million |
| Research and Development Expenses | 165.94 Thousand | 544.04 Thousand | 216.43 Thousand | 398.42 Thousand | - | - |
| Other Expenses | 200.89 Thousand | - | - | - | - | 3.03 Million |
| Cost and Expenses | 9.78 Million | 11.44 Million | 9.37 Million | 6.55 Million | 3.26 Million | 3.12 Million |
| Operating Income | -6.76 Million | -10.62 Million | -5.21 Million | -5.51 Million | -1.78 Million | -2.63 Million |
| Interest Expense | 925.9 Thousand | 59.44 Thousand | 1.26 Million | 2.83 Million | 379.01 Thousand | 442.03 Thousand |
| Income Tax Expense | 27.78 Thousand | 2872.00 | 4764.00 | 36.00 | 433.00 | -155.95 Thousand |
| Earnings before Tax | -8 Million | -10.88 Million | -6.65 Million | -8.34 Million | -2.16 Million | -3.07 Million |
| Net Income | -8.03 Million | -10.89 Million | -6.65 Million | -8.34 Million | -2.16 Million | -3.07 Million |
| Earnings Per Share Basic | -5.13 | -17.97 | -12.52 | -30.41 | -8.93 | -12.76 |
| Earnings Per Share Diluted | -5.13 | -17.97 | -12.52 | -30.41 | -8.93 | -12.76 |
| Weighted Average Shares Outstanding | 1.56 Million | 606.13 Thousand | 531.62 Thousand | 274.48 Thousand | 242.74 Thousand | 241.08 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.56 Million | 606.13 Thousand | 531.62 Thousand | 274.48 Thousand | 242.74 Thousand | 241.08 Thousand |
| Gross Margin | 0.36 | 0.60 | 0.97 | 0.91 | 0.91 | 0.82 |
| EBIT Margin | -2.19 | -13.17 | -1.29 | -5.31 | -1.21 | -5.32 |
| Profit Margin | -2.66 | -13.25 | -1.60 | -8.05 | -1.46 | -6.22 |
| EBITDA | -6.88 Million | -10.52 Million | -5.21 Million | -5.47 Million | -1.76 Million | -2.62 Million |
| Earnings Before Tax Margin | -2.24 | -12.92 | -1.25 | -5.32 | -1.21 | -5.33 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.83 Million | 1.57 Million | 1.38 Million | 3.02 Million | 974.89 Thousand | 315.9 Thousand |
| Cost of Revenue | 1.09 Million | 1.07 Million | 886.75 Thousand | 1.93 Million | 580.96 Thousand | 255.41 Thousand |
| Gross Profit | 744.61 Thousand | 499.09 Thousand | 495 Thousand | 1.08 Million | 393.92 Thousand | 60.48 Thousand |
| Operating Expenses | 2.64 Million | 1.44 Million | 2 Million | 7.85 Million | 1.28 Million | 2.12 Million |
| Selling, General and Administrative Expenses | 2.64 Million | 1.44 Million | 1.85 Million | - | 1.25 Million | 2.04 Million |
| Research and Development Expenses | - | 4880.00 | 5907.00 | - | 2668.00 | 83.85 Thousand |
| Other Expenses | 230.33 Million | 226.96 Thousand | 180.39 Thousand | 200.89 Thousand | 20.5 Thousand | 19.7 Thousand |
| Cost and Expenses | 3.73 Million | 2.52 Million | 2.89 Million | 9.78 Million | 1.86 Million | 2.38 Million |
| Operating Income | -1.9 Million | -946.37 Thousand | -1.5 Million | -6.76 Million | -886.29 Thousand | -2.06 Million |
| Interest Expense | 369.61 Thousand | 181.29 Thousand | 182.04 Thousand | 925.9 Thousand | 352.08 Thousand | 175.19 Thousand |
| Income Tax Expense | 2.00 | 1836.00 | 23.03 Thousand | 27.78 Thousand | 1886.00 | 2865.00 |
| Earnings before Tax | -2.24 Million | -1.59 Million | -1.97 Million | -8 Million | -1.24 Million | -2.23 Million |
| Net Income | -2.24 Million | -1.59 Million | -1.99 Million | -8.03 Million | -1.24 Million | -2.24 Million |
| Earnings Per Share Basic | -0.62 | -0.42 | -1.27 | - | -0.70 | -3.06 |
| Earnings Per Share Diluted | -0.62 | -0.42 | -1.27 | - | -0.70 | -3.06 |
| Weighted Average Shares Outstanding | 3.6 Million | 3.8 Million | 1.56 Million | 1.56 Million | 1.77 Million | 732.25 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.6 Million | 3.8 Million | 1.56 Million | 1.56 Million | 1.77 Million | 732.25 Thousand |
| Gross Margin | 0.41 | 0.32 | 0.36 | 0.36 | 0.40 | 0.19 |
| EBIT Margin | -0.91 | -0.46 | -1.01 | - | -0.90 | -6.53 |
| Profit Margin | -1.22 | -1.01 | -1.44 | -2.66 | -1.28 | -7.09 |
| EBITDA | -1.67 Million | -719.41 Thousand | -1.39 Million | - | -873.94 Thousand | -2.06 Million |
| Earnings Before Tax Margin | -1.04 | -0.60 | -1.09 | -2.24 | -0.91 | -6.54 |
CBAN
0L7F
MRG
IWG
9245
CINF